Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Holly Mitchell

Dados Biográficos

ID7789124
NOMEHolly Mitchell
PRENOMESHolly
SOBRENOMEMitchell
ASSINATURAMITCHELL H
AFILIAÇÕESUK Health Security Agency
ORCID0000-0002-6103-9975
VERIFICADONão
TOTAL DE OBRAS5
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR5
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2025
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H0
  • PrEPped for Covid? The association between HIV-PrEP use and Covid-19 among men and gender diverse people who have sex with men

    Open Access•Caisey V Pulford, Holly Mitchell et al.•ARTICLE•BMC Public Health•2026

    Oral tenofovir and emtricitabine taken as pre-exposure prophylaxis (HIV-PrEP) is highly effective at reducing Human Immunodeficiency Virus (HIV) acquisition. Nucleotide analogues have also been shown to inhibit Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) polymerase activity in vitro, raising the question as to whether tenofovir-based HIV-PrEP could be useful for the prevention and treatment of COVID-19. We sought to examine the a…

  • Characterising benzodiazepine use and the association with non-fatal overdose among people who inject opioids in England, Wales and Northern Ireland

    Open Access•Megan Minett-Smith, Holly D Mitchell et al.•ARTICLE•International Journal of Drug…•2025

    Benzodiazepine use is common among PWIO in England, Wales, and Northern Ireland, and is associated with higher prevalence of non-fatal overdose. These findings underscore the need to strengthen overdose prevention and harm reduction efforts addressing benzodiazepine use across the UK

  • Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals

    Open Access•Harriet D Gliddon, Zoë Ward et al.•ARTICLE•International Journal of Drug…•2025

    COC stages from seeing a specialist onwards improved after DAAs became widely available. Further improvements in HCV testing are needed to eliminate HCV in England

  • Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches …

    Open Access•Holly D Mitchell, Holly Mitchell et al.•ARTICLE•International Journal of Drug…•2025

  • Analysing HCV incidence trends in people who inject drugs using serial behavioural and seroprevalence data

    Open Access•Conor Egan, Ross J Harris et al.•ARTICLE•International Journal of Drug…•2025

    Fractional polynomials provided an adequate fit with relatively few parameters, but splines may be preferable to ensure flexibility, in particular, to detect short-term changes in the rate of first infection over time that may be a result of treatment effects. Although chronic HCV prevalence has declined with treatment scale up over 2016-2020, there is no evidence yet of a corresponding fall in the rate of first infection. Seroprevalence and risk…

Sem obras proeminentes nesta página.

  • Characterising benzodiazepine use and the association with non-fatal overdose among people who inject opioids in England, Wales and Northern Ireland

    Open Access•Megan Minett-Smith, Holly D Mitchell et al.•ARTICLE•International Journal of Drug…•2025

    Benzodiazepine use is common among PWIO in England, Wales, and Northern Ireland, and is associated with higher prevalence of non-fatal overdose. These findings underscore the need to strengthen overdose prevention and harm reduction efforts addressing benzodiazepine use across the UK

  • Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals

    Open Access•Harriet D Gliddon, Zoë Ward et al.•ARTICLE•International Journal of Drug…•2025

    COC stages from seeing a specialist onwards improved after DAAs became widely available. Further improvements in HCV testing are needed to eliminate HCV in England

  • Using modelling and public health surveillance data to evidence progress towards the WHO incidence target for hepatitis C elimination in people who inject drugs - a review of complementary approaches …

    Open Access•Holly D Mitchell, Holly Mitchell et al.•ARTICLE•International Journal of Drug…•2025

  • Analysing HCV incidence trends in people who inject drugs using serial behavioural and seroprevalence data

    Open Access•Conor Egan, Ross J Harris et al.•ARTICLE•International Journal of Drug…•2025

    Fractional polynomials provided an adequate fit with relatively few parameters, but splines may be preferable to ensure flexibility, in particular, to detect short-term changes in the rate of first infection over time that may be a result of treatment effects. Although chronic HCV prevalence has declined with treatment scale up over 2016-2020, there is no evidence yet of a corresponding fall in the rate of first infection. Seroprevalence and risk…

  • PrEPped for Covid? The association between HIV-PrEP use and Covid-19 among men and gender diverse people who have sex with men

    Open Access•Caisey V Pulford, Holly Mitchell et al.•ARTICLE•BMC Public Health•2026

    Oral tenofovir and emtricitabine taken as pre-exposure prophylaxis (HIV-PrEP) is highly effective at reducing Human Immunodeficiency Virus (HIV) acquisition. Nucleotide analogues have also been shown to inhibit Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) polymerase activity in vitro, raising the question as to whether tenofovir-based HIV-PrEP could be useful for the prevention and treatment of COVID-19. We sought to examine the a…

Hepatitis C (3 obras) · Hepatitis C virus (3 obras) · Hepatitis C virus research (3 obras) · Medicine (3 obras) · Chronic hepatitis (2 obras) · HIV, Drug Use, Sexual Risk (2 obras) · HIV/AIDS Research and Interventions (2 obras) · Incidence (geometry (2 obras) · Internal Medicine (2 obras) · Logistic regression (2 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae